Clinical Trial Update: Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of clofarabine and daunorubicin in older patients with newly diagnosed acute myeloid leukemia was terminated, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine (clofarabine)
• Daunorubicin (daunorubicin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-08-17